Pharmacokinetics and Safety Study of Omecamtiv Mecarbil in Healthy Japanese Adults

NCT02601001 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Omecamtiv mecarbil
DRUG: Placebo

Sponsor

Cytokinetics